Literature DB >> 14669336

Relationship between clinical and pathologic findings in patients with chronic liver diseases.

Lun-Gen Lu1, Min-De Zeng, Yi-Min Mao, Ji-Qiang Li, De-Kai Qiu, Jing-Yuan Fang, Ai-Ping Cao, Mo-Bin Wan, Cheng-Zhong Li, Jun Ye, Xiong Cai, Cheng-Wei Chen, Ji-Yao Wang, Shan-Ming Wu, Jin-Shui Zhu, Xia-Qiu Zhou.   

Abstract

AIM: To explore the relationship between clinical findings of patients with chronic liver diseases and the pathologic grading and staging of liver tissues.
METHODS: The inflammatory activity and fibrosis of consecutive liver biopsies from 200 patients were determined according to the diagnosis criteria of chronic hepatitis in China established in 1995. A comparative analysis was carried out for 200 patients with chronic liver diseases by comparing their clinical manifestations, serum biochemical markers with the grading and staging of liver tissues.
RESULTS: It was revealed that age, index of clinical symptoms and physical signs were obviously relevant to the pathologic grading and staging of liver tissues (P<0.05). Blood platelet, red blood cells, aspartate aminotransferase (AST), N-terminal procollagen III (PIII NP) were apparently correlated with the degree of inflammation. PGA (prothrombin time, GGT, apoprotein A1) index, PGAA (PGA+delta2-macroglobulin) index, albumin and albumin/globulin were relevant to both inflammation and fibrosis. Hyaluronic acid (HA) was an accurate variable for the severity of hepatic inflammation and fibrosis. The combination of serum markers for fibrosis could increase the diagnostic accuracy. It was notable that viral replication markers were not relevant to the degree of inflammation and fibrosis.
CONCLUSION: There is a good correlation between clinical findings and the pathologic grading and staging of liver tissues, which may give aid to the noninvasive diagnosis of liver fibrosis.

Entities:  

Mesh:

Year:  2003        PMID: 14669336      PMCID: PMC4612055          DOI: 10.3748/wjg.v9.i12.2796

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  39 in total

Review 1.  Advances in gene therapy of liver cirrhosis: a review.

Authors:  W J Dai; H C Jiang
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

2.  PGA score in diagnosis of alcoholic fibrosis.

Authors:  J J Jiang; M Salvucci; V Thepot; S Pol; O G Ekindjian; B Nalpas
Journal:  Lancet       Date:  1994-03-26       Impact factor: 79.321

3.  Serum procollagen peptides and collagen type VI for the assessment of activity and degree of hepatic fibrosis in schistosomiasis and alcoholic liver disease.

Authors:  M Shahin; D Schuppan; R Waldherr; J Risteli; L Risteli; E R Savolainen; C Oesterling; H M Abdel Rahman; A M el Sahly; S M Abdel Razek
Journal:  Hepatology       Date:  1992-04       Impact factor: 17.425

4.  Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis.

Authors:  C Aubé; F Oberti; N Korali; M A Namour; D Loisel; J Y Tanguy; E Valsesia; C Pilette; M C Rousselet; P Bedossa; H Rifflet; M Y Maïga; D Penneau-Fontbonne; C Caron; P Calès
Journal:  J Hepatol       Date:  1999-03       Impact factor: 25.083

5.  Serum collagen type VI and XIV and hyaluronic acid as early indicators for altered connective tissue turnover in alcoholic liver disease.

Authors:  F Stickel; R Urbaschek; D Schuppan; G Poeschl; C Oesterling; C Conradt; R S McCuskey; U A Simanowski; H K Seitz
Journal:  Dig Dis Sci       Date:  2001-09       Impact factor: 3.199

6.  Diagnostic value of serum markers of connective tissue turnover for predicting histological staging and grading in patients with chronic hepatitis C.

Authors:  Y Murawaki; Y Ikuta; K Okamoto; M Koda; H Kawasaki
Journal:  J Gastroenterol       Date:  2001-06       Impact factor: 7.527

7.  Noninvasive diagnosis of hepatic fibrosis or cirrhosis.

Authors:  F Oberti; E Valsesia; C Pilette; M C Rousselet; P Bedossa; C Aubé; Y Gallois; H Rifflet; M Y Maïga; D Penneau-Fontbonne; P Calès
Journal:  Gastroenterology       Date:  1997-11       Impact factor: 22.682

8.  Prothrombin index is an indirect marker of severe liver fibrosis.

Authors:  Vincent Croquet; Eric Vuillemin; Catherine Ternisien; Christophe Pilette; Frédéric Oberti; Yves Gallois; Marc Trossaert; Marie Christine Rousselet; Daniel Chappard; Paul Calès
Journal:  Eur J Gastroenterol Hepatol       Date:  2002-10       Impact factor: 2.566

9.  Prothrombin index decrease: a useful and reliable marker of extensive fibrosis?

Authors:  Jean-Francois Cadranel; Philippe Mathurin
Journal:  Eur J Gastroenterol Hepatol       Date:  2002-10       Impact factor: 2.566

10.  Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis.

Authors:  J Guéchot; A Laudat; A Loria; L Serfaty; R Poupon; J Giboudeau
Journal:  Clin Chem       Date:  1996-04       Impact factor: 8.327

View more
  8 in total

1.  Diagnostic accuracy of serum biochemical fibrosis markers in children with chronic hepatitis B evaluated by receiver operating characteristics analysis.

Authors:  Dariusz Marek Lebensztejn; Elzbieta Skiba; Jolanta Tobolczyk; Maria Elzbieta Sobaniec-Lotowska; Maciej Kaczmarski
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

Review 2.  From bed to bench: which attitude towards the laboratory liver tests should health care practitioners strike?

Authors:  Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

3.  Liver fibrosis and tissue architectural change measurement using fractal-rectified metrics and Hurst's exponent.

Authors:  Nicola Dioguardi; Fabio Grizzi; Barbara Franceschini; Paola Bossi; Carlo Russo
Journal:  World J Gastroenterol       Date:  2006-04-14       Impact factor: 5.742

4.  Extent of liver inflammation in predicting response to interferon α & Ribavirin in chronic hepatitis C patients: a cohort study.

Authors:  Shirin Mirza; Amna Rehana Siddiqui; Saeed Hamid; Muhammad Umar; Shaheena Bashir
Journal:  BMC Gastroenterol       Date:  2012-06-14       Impact factor: 3.067

Review 5.  Non-invasive markers for hepatic fibrosis.

Authors:  Ancha Baranova; Priyanka Lal; Aybike Birerdinc; Zobair M Younossi
Journal:  BMC Gastroenterol       Date:  2011-08-17       Impact factor: 3.067

Review 6.  Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis C virus.

Authors:  Savino Bruno; Daniela Savojardo; Piero L Almasio; Mario U Mondelli
Journal:  Hepat Med       Date:  2011-03-30

7.  Evaluation of the relation between hepatic fibrosis and basic laboratory parameters in patients with chronic hepatitis B fibrosis and basic laboratory parameters.

Authors:  Nazlim Aktug Demir; Servet Kolgelier; Serap Ozcimen; Gokhan Gungor; Sua Sumer; Lutfi Saltuk Demir; Ahmet Cagkan Inkaya; Onur Ural
Journal:  Hepat Mon       Date:  2014-04-01       Impact factor: 0.660

8.  Red blood cell distribution width levels correlate with liver fibrosis and inflammation: a noninvasive serum marker panel to predict the severity of fibrosis and inflammation in patients with hepatitis B.

Authors:  Wen-Shen Xu; Xiao-Ming Qiu; Qi-Shui Ou; Can Liu; Jin-Piao Lin; Hui-Juan Chen; Sheng Lin; Wen-Hua Wang; Shou-Rong Lin; Jing Chen
Journal:  Medicine (Baltimore)       Date:  2015-03       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.